TRIM34 suppresses non-small-cell lung carcinoma via inducing mTORC1-dependent glucose utilization and promoting cellular death
Archives of Biochemistry and Biophysics · 2024-04 · 754 · 109925
DOI: 10.1016/j.abb.2024.109925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2024-04. Verfasst von Pengfei Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chinese PLA Medical School, Beijing, 100853, China; Department of Oncology, First Medical Center of Chinese PLA General Hospital, Beijing, 100853, Ch…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Non-small-cell lung carcinoma (NSCLC) is a type of pernicious tumor, which owns high morbidity and mortality. TRIM34 has a stimulative role in cell apoptosis and a suppressive role in inflammation. However, no studies were focused on the regulatory impacts of TRIM34 in NSCLC. This study aimed to examine the underlying regulatory effects of TRIM34 in NSCLC. TRIM34 exhibited lower expression in NSCLC. TRIM34 facilitated mitochondrial damage and apoptosis in NSCLC. TRIM34 induced the increased activity of mTORC1 and accelerated glycolysis in NSCLC. Enhanced mitochondrial damage induced by TRIM34 overexpression was reversed after rapamycin (mTORC1 inhibitor) treatment in NSCLC. The strengthened cell apoptosis stimulated by TRIM34 overexpression was rescued after rapamycin treatment. TRIM34 activated mTORC1 to suppress NSCLC progression in vivo. TRIM34 suppressed NSCLC via inducing mTORC1-dependent glucose utilization and promoting cellular death. The results suggest that TRIM34 can be a useful therapeutic biomarker for NSCLC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chinese PLA Medical School, Beijing, 100853, China; Department of Oncology, First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
- Department of General Surgery, First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
- Department of Oncology, First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
- Department of Oncology, First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China. Electronic address: huyi301zlxb@sina.com.
Zitieren
APA
Zhang, P., Chen, Z., Li, J., Mao, H., & Hu, Y. (2024). TRIM34 suppresses non-small-cell lung carcinoma via inducing mTORC1-dependent glucose utilization and promoting cellular death. Archives of Biochemistry and Biophysics, 754, 109925. https://doi.org/10.1016/j.abb.2024.109925
Vancouver
Zhang P, Chen Z, Li J, Mao H, Hu Y. TRIM34 suppresses non-small-cell lung carcinoma via inducing mTORC1-dependent glucose utilization and promoting cellular death. Archives of Biochemistry and Biophysics. 2024;754:109925. doi:10.1016/j.abb.2024.109925
BibTeX
@article{Zhang2024,
author = {Zhang, Pengfei and Chen, Zhida and Li, Juan and Mao, Hui and Hu, Yi},
title = {TRIM34 suppresses non-small-cell lung carcinoma via inducing mTORC1-dependent glucose utilization and promoting cellular death},
journal = {Archives of Biochemistry and Biophysics},
year = {2024},
volume = {754},
pages = {109925},
doi = {10.1016/j.abb.2024.109925}
}
EUVIMED